论文部分内容阅读
目的评价美能与甘利欣治疗儿童病毒性肝损害的临床疗效。方法 2009年6月—2011年6月选择病毒性肝损害患儿128例,随机分为治疗组65例,对照组63例,治疗组给予美能1.5 mg/kg,静脉滴注,1次/d;对照组给予甘利欣3mg/kg,静脉滴注,1次/d,两组均连续治疗10 d。结果治疗组总有效率96.92%,对照组总有效率80.95%,治疗组疗效优于对照组。结论美能治疗病毒性肝损害比甘利欣疗效好。
Objective To evaluate the clinical efficacy of the beauty and Glycyrrhizin in the treatment of viral liver damage in children. Methods From June 2009 to June 2011, 128 children with viral liver damage were randomly divided into treatment group (n = 65) and control group (n = 63). The treatment group was treated with 1.5 mg / kg of benevolence, once daily ; The control group was given Glycyrrhizin 3mg / kg, intravenous infusion, 1 / d, two groups were treated for 10 days. Results The total effective rate was 96.92% in the treatment group and 80.95% in the control group. The curative effect in the treatment group was better than that in the control group. Conclusions The United States to treat viral liver damage than Gan Lixin good effect.